Vedolizumab Biosimilar - Research Grade

Vedolizumab Biosimilar - Research Grade, Host: Humanized, IgG1

Target: Integrin α4β7.

Specificity: Detects human Integrin α4β7. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Vedolizumab.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Vedolizumab, an integrin receptor antagonist, is a humanized IgG1 monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. Vedolizumab has an approximate molecular weight of 147 kilodaltons.

Concentration: 1.0 - 5.0 mg/ml.

Formulation: Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

Purity: >95% by SDS-PAGE and HPLC.

Endotoxin: ≤ 0.75 EU/mg as determined by the LAL method.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.

• Artikelnummer: ICH4035-20MG
• Hersteller: Ichorbio
• Hersteller Artikelnummer: ICH4035-20MG
• Verpackungseinheit: 20mg
• Mengeneinheit: STK
• Reaktivität: Human
• Klonalität: Monoclonal
• Isotyp: IgG1
• Wirt: Humanized